NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company, today announced the presentation of its COMMAND study results at the 2024 Congress of Neurological Surgeons (CNS) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Interim results from the COMMAND study evaluating the ...

NEW YORK--(BUSINESS WIRE)--Synchron, the endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, today announced the ...

The early feasibility study (EFS), funded by the National Institutes of Health (NIH), will primarily assess safety and begin to explore quantified efficacy measures of Synchron’s Stentrode™ in ...

Brain-computer interfaces have become a practical (if limited) reality in the US. Synchron says it has become the first in the country to implant a BCI in a human patient. Doctors in New York's Mount ...

Elon Musk's Neuralink rival Synchron has begun human trials of its brain implant that lets the wearer control a computer using thought alone. The firm's Stentrode brain implant, about the size of a ...

Synchron, a brain-data transfer company, is jumping to the forefront of the Brain-Computer Interface, (BCI) market with two huge milestones. The New York-based company won FDA approval for an IDE of ...

New York-based Synchron, a brain-computer interface (BCI) company, has released a video showing an ALS patient using an iPad controlled entirely by thought in what it says is the "first-ever public ...